Bonumose
produces high-volume, naturally occurring monosaccharides from commodity starch and sugar using innovative enzyme combinations, and partnered with Allozymes in 2025 to accelerate enzyme innovation.
- Country
- United States
Coverage
| EU | IN | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Rare sugars and enzymatic sweeteners | food-alt-protein | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.